Besides, immunochemistry analysis showed that ACLY expression was evidently decreased in the tumor tissues of IGF2BP1 knockout group or NONO knockout group, compared to that in control group (Fig. 7b). The gene discussed is IGF2BP1; the disease is neoplasm.